StockDuty ← Dashboard Aug 19, 2026 11:16 AM ET
CatalystFDA/Bio

GUARDANT HEALTH ( GH ) SURGES ON FDA APPROVAL AND CANCER SCREENING MOMENTUM

FDA approval catalyst and cancer screening momentum drive Guardant Health's surge.

What changed
Why it matters
FDA approval catalyst and cancer screening momentum drive Guardant Health's surge.
Sources
gdelt
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →